NASDAQ:ZLAB Zai Lab Q2 2026 Earnings Results & Report $26.04 -0.38 (-1.44%) Closing price 04:00 PM EasternExtended Trading$26.49 +0.45 (+1.74%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Zai Lab reported Q2 2026 earnings on June 30, 2026. The company reported EPS of -$0.50, while revenue was $106.31 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateJune 30, 2026TimeBefore Market Opens Zai Lab EPS ResultsActual EPS-$0.50Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AEPS Beat Rate4 of last 8 quartersZai Lab Revenue ResultsActual Revenue$106.31 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Zai Lab Q2 2026 Earnings FAQ Did Zai Lab beat earnings estimates for Q2 2026? Zai Lab (NASDAQ:ZLAB) reported earnings of -$0.50 per share for Q2 2026. The report was announced on Tuesday, June 30, 2026. What was Zai Lab's revenue for Q2 2026? Zai Lab reported revenue of $106.31 million for Q2 2026. Zai Lab Earnings HeadlinesZai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Stock Has Average Price Target of $37.25 According to AnalystsNovember 12 at 2:15 AM | americanbankingnews.comZai Lab Limited announced that it has received $249.9336 million in funding from a group of investorsNovember 10 at 10:02 AM | marketscreener.comMA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 12 at 1:00 AM | Behind the Markets (Ad)Zai Lab Limited 2026 Q3 - Results - Earnings Call PresentationNovember 9 at 6:33 PM | seekingalpha.comZai Lab (NASDAQ:ZLAB) Shares Up 13% Following Better-Than-Expected EarningsNovember 8, 2026 | americanbankingnews.comZai Lab (ZLAB) Draws Fresh Optimism, Is The Stock Still 24% Undervalued?November 7, 2026 | finance.yahoo.comSee More Zai Lab Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Zai Lab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zai Lab and other key companies, straight to your email. Email Address About Zai LabZai Lab (NASDAQ:ZLAB) is a biopharmaceutical company that discovers, develops and commercializes medicines for patients with serious diseases. Its research and development programs focus on oncology, immunology, neuroscience and infectious diseases. Founded in 2014 by biopharmaceutical executive Samantha Du, the company is headquartered in Shanghai and operates in China and the United States. It advances its own drug candidates and works with international partners to develop and bring therapies to market. Zai Lab’s portfolio includes medicines and development programs for cancers and other conditions, including therapies introduced through licensing and collaboration agreements. These partnerships support the company’s efforts to develop treatments for patients in China and other markets.View Zai Lab ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Bounced Back 9%, But Its Earnings Reveal a Costly Trade-OffSix Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping3 Pharmaceutical Stocks That Offer Safety and GrowthKeeping AI Cool: AAON Rides the AI Heatwave to Record GrowthPalantir’s Real Washington Risk Isn’t the Budget—It’s OversightCoreWeave's Backlog Is Surging—Can the Stock Follow?Can Constellation Energy's Contracts Power a Stock Rebound? Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
